Clinical trial
Parnaparin Versus Aspirin in the Treatment of Retinal Vein Occlusion. A Randomized, Double Blind, Controlled Study
NCT00732927 is registered in ClinicalTrials.gov with Università degli Studi dell'Insubria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Parnaparin Versus Aspirin in the Treatment of Retinal Vein Occlusion. A Randomized, Double Blind, Controlled Study
- Lead sponsor
- Università degli Studi dell'Insubria
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2002
- Completion date
- September 30, 2007
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.